• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析影响晚期胃癌患者生存的多种因素。

Analysis of multiple factors influencing the survival of patients with advanced gastric cancer.

机构信息

The Affiliated Suqian Hospital of Xuzhou Medical University, Suqian, Jiangsu 223800, PR China.

Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212000, PR China.

出版信息

Aging (Albany NY). 2024 May 13;16(10):8541-8551. doi: 10.18632/aging.205820.

DOI:10.18632/aging.205820
PMID:38742950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11164492/
Abstract

OBJECTIVE

The aim of this study was to investigate the main factors influencing the survival of patients with advanced gastric cancer.

METHODS

The clinicopathological data of 120 patients with advanced gastric cancer were analyzed retrospectively, and clinical and pathological data were collected. Tumor tissue staging and grading were re-evaluated, and 5-year overall survival was followed up. The classified data were described by percentages, and the continuous data were described by standard deviations or medians. Univariate analysis was performed using the χ test or rank-sum test, followed by Kaplan-Meier survival analysis to calculate the median survival time and 5-year cumulative survival. A multivariate Cox regression model was used to evaluate the independent risk factors affecting survival. The test level was α = 0.05.

RESULTS

Patients were followed up for 0 to 60 months, the 5-year overall survival rate was 36.2%, and the median survival time was 53.0 ± 1.461 months. K-M and log-rank test results revealed that tumor location, degree of differentiation, depth of invasion, regional lymph node involvement, and postoperative tumor stage were correlated with a decreased 5-year survival rate ( < 0.05). A multivariate Cox risk regression model was used to analyze the degree of histological differentiation (HR = 1.441; 95% CI = 1.049-1.979; = 0.024), regional lymph node (HR = 1.626; 95% CI = 1.160-2.279; = 0.005), and pTNM stage (HR = 2.266; 95% CI = 1.335-3.847; = 0.002), which are independent risk factors for poor survival. Tumor location ( = 0.191), invasion depth ( = 0.579) and tumor size ( = 0.324) were not found to be independent risk factors.

CONCLUSION

The degree of tumor differentiation, regional lymph node metastasis and postoperative pathological stage were found to be independent risk factors for 5-year overall survival in patients with advanced gastric cancer. Standardized and reasonable lymph node dissection and accurate postoperative pathological staging were very important.

摘要

目的

本研究旨在探讨影响晚期胃癌患者生存的主要因素。

方法

回顾性分析 120 例晚期胃癌患者的临床病理资料,收集临床和病理资料。重新评估肿瘤组织分期和分级,随访 5 年总生存率。分类数据用百分比描述,连续数据用标准差或中位数描述。采用 χ²检验或秩和检验进行单因素分析,然后进行 Kaplan-Meier 生存分析计算中位生存时间和 5 年累积生存率。采用多因素 Cox 回归模型评估影响生存的独立危险因素。检验水准α=0.05。

结果

患者随访 060 个月,5 年总生存率为 36.2%,中位生存时间为 53.0±1.461 个月。K-M 和对数秩检验结果显示,肿瘤部位、分化程度、浸润深度、区域淋巴结转移和术后肿瘤分期与 5 年生存率降低相关(<0.05)。采用多因素 Cox 风险回归模型分析组织学分化程度(HR=1.441;95%CI=1.0491.979;=0.024)、区域淋巴结(HR=1.626;95%CI=1.1602.279;=0.005)和 pTNM 分期(HR=2.266;95%CI=1.3353.847;=0.002)是生存不良的独立危险因素。肿瘤部位(=0.191)、浸润深度(=0.579)和肿瘤大小(=0.324)未发现是独立危险因素。

结论

肿瘤分化程度、区域淋巴结转移和术后病理分期是影响晚期胃癌患者 5 年总生存率的独立危险因素。规范化、合理的淋巴结清扫和准确的术后病理分期非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c8/11164492/1c282a4bdee7/aging-16-205820-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c8/11164492/2e6ba682a6bc/aging-16-205820-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c8/11164492/de07adc55fb4/aging-16-205820-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c8/11164492/6bc004087949/aging-16-205820-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c8/11164492/1c282a4bdee7/aging-16-205820-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c8/11164492/2e6ba682a6bc/aging-16-205820-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c8/11164492/de07adc55fb4/aging-16-205820-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c8/11164492/6bc004087949/aging-16-205820-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c8/11164492/1c282a4bdee7/aging-16-205820-g004.jpg

相似文献

1
Analysis of multiple factors influencing the survival of patients with advanced gastric cancer.分析影响晚期胃癌患者生存的多种因素。
Aging (Albany NY). 2024 May 13;16(10):8541-8551. doi: 10.18632/aging.205820.
2
[Prognostic factors of lymph node-negative metastasis gastric cancer].[淋巴结阴性转移性胃癌的预后因素]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Feb 25;20(2):190-194.
3
[Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].[预后营养指数在进展期胃癌患者中的临床意义]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):180-184.
4
[Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].[淋巴管浸润对Ⅰ期胃癌患者根治性胃切除术后预后的影响]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):175-179.
5
[Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].42例原发性胃腺鳞癌患者的临床病理特征及预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Feb 25;20(2):207-212.
6
[Analysis of risk factors and prognosis of No.8p lymph node metastasis in cases with advanced gastric cancer].[进展期胃癌患者8p区淋巴结转移的危险因素及预后分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Feb 25;20(2):218-223.
7
[Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].[单中心501例胃神经内分泌肿瘤患者的临床病理特征、治疗策略及预后分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 May 25;26(5):459-466. doi: 10.3760/cma.j.cn441530-20220512-00212.
8
Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.血清纤维蛋白原水平与接受胃切除术的胃癌患者的肿瘤晚期和不良生存呈正相关:一项大型队列回顾性研究。
BMC Cancer. 2016 Jul 14;16:480. doi: 10.1186/s12885-016-2510-z.
9
[Analysis of prognosis and influencing factors of No. 253 lymph node metastasis in descending colon, sigmoid colon, and rectal cancer: a multicenter study].降结肠癌、乙状结肠癌及直肠癌第253组淋巴结转移的预后及影响因素分析:一项多中心研究
Zhonghua Wai Ke Za Zhi. 2023 Sep 1;61(9):760-767. doi: 10.3760/cma.j.cn112139-20230331-00132.
10
Clinicopathologic characteristics in patients with upper third gastric cancer following radical surgical treatment: A retrospective cohort study.根治性手术治疗后胃上部癌患者的临床病理特征:一项回顾性队列研究。
Medicine (Baltimore). 2018 Nov;97(45):e13017. doi: 10.1097/MD.0000000000013017.

引用本文的文献

1
Factors influencing the incidence of early gastric cancer: a bayesian network analysis.影响早期胃癌发病率的因素:贝叶斯网络分析
BMC Gastroenterol. 2025 Mar 21;25(1):194. doi: 10.1186/s12876-025-03765-7.
2
ATP7A as a prognostic biomarker and potential therapeutic target in gastric cancer.ATP7A作为胃癌的一种预后生物标志物和潜在治疗靶点。
Am J Transl Res. 2025 Jan 15;17(1):512-527. doi: 10.62347/UYMP7222. eCollection 2025.
3
Risk factors of positive lymph node metastasis after radical gastrectomy for gastric cancer and construction of prediction models.

本文引用的文献

1
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023.中国临床肿瘤学会(CSCO):胃癌诊断与治疗临床实践指南,2023 年版。
Cancer Commun (Lond). 2024 Jan;44(1):127-172. doi: 10.1002/cac2.12516. Epub 2023 Dec 31.
2
Long non-coding RNA signature for predicting gastric cancer survival based on genomic instability.基于基因组不稳定性的长非编码 RNA signature 预测胃癌生存。
Aging (Albany NY). 2023 Dec 20;15(24):15114-15133. doi: 10.18632/aging.205336.
3
Prognostic and predictive values of the grading system of lymph node status in patients with advanced-stage gastric cancer.
胃癌根治性切除术后淋巴结转移阳性的危险因素及预测模型的构建
Am J Cancer Res. 2024 Nov 15;14(11):5216-5229. doi: 10.62347/PEDV7297. eCollection 2024.
晚期胃癌患者淋巴结状态分级系统的预后及预测价值
Front Oncol. 2023 Jun 13;13:1183784. doi: 10.3389/fonc.2023.1183784. eCollection 2023.
4
Analysis of the efficacy and influencing factors of preoperative P-SOX neoadjuvant chemotherapy regimen for progressive gastric cancer-construction of a clinical prediction model.术前 P-SOX 新辅助化疗方案治疗进展期胃癌的疗效及影响因素分析-临床预测模型的构建。
Cancer Med. 2023 Jun;12(12):13031-13040. doi: 10.1002/cam4.5977. Epub 2023 Apr 25.
5
Analysis of risk factors for lymph node metastasis and prognosis study in patients with early gastric cancer: A SEER data-based study.早期胃癌患者淋巴结转移危险因素分析及预后研究:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Oncol. 2023 Mar 17;13:1062142. doi: 10.3389/fonc.2023.1062142. eCollection 2023.
6
Tumor Immunophenotyping-Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer.肿瘤免疫表型衍生特征可鉴定胃癌的预后和新辅助免疫治疗反应性。
Adv Sci (Weinh). 2023 May;10(15):e2207417. doi: 10.1002/advs.202207417. Epub 2023 Mar 30.
7
Neutrophil/lymphocyte ratio predicts lymph node metastasis in patients with gastric cancer.中性粒细胞与淋巴细胞比值可预测胃癌患者的淋巴结转移情况。
Am J Transl Res. 2023 Feb 15;15(2):1412-1420. eCollection 2023.
8
Perioperative nutrition management for gastric cancer.胃癌患者围手术期的营养管理。
Nutrition. 2022 Jan;93:111492. doi: 10.1016/j.nut.2021.111492. Epub 2021 Sep 20.
9
Clinicopathological Analysis and Prognostic Assessment of TCN1 in Patients with Gastric Cancer.胃癌患者 TCN1 的临床病理分析与预后评估。
Surg Innov. 2022 Oct;29(5):557-565. doi: 10.1177/15533506211045318. Epub 2021 Sep 22.
10
Role of poorly differentiated cluster in gastric cancer: is it a new prognosis factor?低分化簇在胃癌中的作用:它是一个新的预后因素吗?
Scand J Gastroenterol. 2022 Jan;57(1):44-49. doi: 10.1080/00365521.2021.1974932. Epub 2021 Sep 15.